跳至主要内容
临床试验/CTRI/2024/06/068904
CTRI/2024/06/068904招募中Phase 3 4

Implementation and Evaluation of an Evidence Based Comprehensive Antimicrobial Stewardship Interventions in Haematological Malignancy Patients

Avvaru Deepthi1 个研究点 分布在 1 个国家目标入组 153 人开始时间: 2024年7月1日最近更新:
适应症

试验速览

阶段
Phase 3 4
状态
招募中
发起方
入组人数
153
试验地点
1
主要终点
To optimise antibiotic therapy through Antimicrobial Stewardship Intervention among Haematological Malignancy patients.

研究概览

简要总结

Cancer patients in India, exhibit a high prevalence to first line antibiotics. Blood stream infections are commonly reported in patients with haematological malignancies. Data is limited regarding epidemiological and antimicrobial resistance pattern among haematological malignancies patients in India. To avoid unnecessary use of broad-spectrum antimicrobials for unspecified durations, it is strongly advised to implement a risk-based strategy. Prudent utilisation of antimicrobials, monitoring resistance patterns through surveillance and engaging an active multidisciplinary are essential for reducing antimicrobial resistance and clinical outcomes.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
Female

入选标准

  • All adults ≥18 years of age diagnosed with HM on antibiotic.
  • Prescribers involved with antibiotic prescription in the treatment of HM patients.
  • Prescribers involved with antibiotic prescription in the treatment of HM patients, multidisciplinary (AMS) team.

排除标准

  • Pregnant and lactating women.
  • Prescribers not involved with HM patients.

结局指标

主要结局

To optimise antibiotic therapy through Antimicrobial Stewardship Intervention among Haematological Malignancy patients.

时间窗: After 6 months

次要结局

  • Prospective audit & feedback by clinical pharmacist will aid in assessing & reducing potentially inappropriate therapy which will improve outcomes.

研究者

发起方
Avvaru Deepthi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Avvaru Deepthi

Kasturba Medical College

研究点 (1)

Loading locations...

相似试验